Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ RGR Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5144876
Description
Immunogen sequence: SLMEQKLGKS GHLQVNTTLP AR Antigen sequence identity: Mouse 68%; Rat 77%.
This gene encodes a putative retinal G-protein coupled receptor. The gene is a member of the opsin subfamily of the 7 transmembrane, G-protein coupled receptor 1 family. Like other opsins which bind retinaldehyde, it contains a conserved lysine residue in the seventh transmembrane domain. The protein acts as a photoisomerase to catalyze the conversion of all-trans-retinal to 11-cis-retinal. The reverse isomerization occurs with rhodopsin in retinal photoreceptor cells. The protein is exclusively expressed in tissue adjacent to retinal photoreceptor cells, the retinal pigment epithelium and Mueller cells. This gene may be associated with autosomal recessive and autosomal dominant retinitis pigmentosa (arRP and adRP, respectively). Alternative splicing results in multiple transcript variants encoding different isoforms.
Specifications
RGR | |
Polyclonal | |
Unconjugated | |
RGR | |
retinal G protein coupled receptor; Rgr; RGR opsin; RGR-opsin; RP44; RPE retinal G-protein coupled receptor; RPE-retinal G protein-coupled receptor | |
Rabbit | |
Affinity chromatography | |
RUO | |
5995 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid | |
IgG |
Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
P47804 | |
RGR | |
Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence. Antigen range: 197-218. Recombinant protein control fragment (Product #RP-109777). | |
100 μL | |
Primary | |
Human | |
Antibody | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction